Both in R&D — Physical & Biological Sciences
Absci vs MaxCyte
Over the past year ABSI returned +143.3% and MXCT returned −7.8%; their daily moves had a correlation of 0.31.
ABSI +143.3% MXCT −7.8%Growth of $1, one year, split-adjusted
| Metric | ABSI | MXCT |
|---|---|---|
| Price | $10.00 | $1.49 |
| Market cap | $1.72B | $153.3M |
| Today | −10.15% | −6.60% |
| 1 month | −9.7% | +38.8% |
| 6 months | +77.9% | +73.1% |
| Year to date | +186.5% | −4.2% |
| 1 year | +144.5% | −1.7% |
| Revenue growth (YoY) | −46.4% | −14.5% |
| Gross margin | 100.0% | 77.0% |
| Net margin | −10443.4% | −122.0% |
| P/E (TTM) | — | — |
| Price / sales | 1,099.4× | 4.9× |
| Net cash | $201.0M | $105.7M |
| Dividend yield | — | — |
| Volatility (60d) | 98.8% | 80.8% |
| Short % of float | 31.0% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).